A Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects with IgA Nephropathy on Sodium-glucose

A Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects with IgA Nephropathy on Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i)

Obert

Codi protocol: CHK01-03
Codi EudraCT: No aplica
Grup de recerca: Nefrologia i Trasplantament Renal
Servei: Nefrologia
Investigador/a principal: Soler Romeo, Maria Jose
Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II